Trellis Advisors, LLC Amgen Inc Transaction History

Trellis Advisors, LLC

$0
Q4 2023

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	BUY	$218.65 - $271.46 $7,215 - $8,958	33 Added 1.46%	2,288 $614,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $2,142 - $2,533	-10 Reduced 0.44%	2,255 $500,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $3,612 - $4,403	-16 Reduced 0.7%	2,265 $547,000
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $4,809 - $6,111	-21 Reduced 0.91%	2,281 $599,000
Q3 2022 Nov 07, 2022	BUY	$224.46 - $253.15 $4,938 - $5,569	22 Added 0.96%	2,302 $518,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $9,920 - $11,039	43 Added 1.92%	2,280 $555,000
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $877 - $970	4 Added 0.18%	2,237 $541,000
Q4 2021 Jan 25, 2022	SELL	$198.88 - $227.6 $6,960 - $7,966	-35 Reduced 1.54%	2,233 $503,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $390,152 - $457,110	-1,838 Reduced 44.76%	2,268 $483,000
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $60,730 - $67,376	-260 Reduced 5.96%	4,106 $1 Million
Q1 2021 May 07, 2021	BUY	$221.91 - $258.6 $2,441 - $2,844	11 Added 0.25%	4,366 $1.09 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $6,924 - $8,245	-32 Reduced 0.73%	4,355 $1 Million
Q3 2020 Oct 29, 2020	BUY	$234.65 - $260.95 $7,743 - $8,611	33 Added 0.76%	4,387 $1.12 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $9,890 - $12,137	-50 Reduced 1.14%	4,354 $1.03 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $18,224 - $24,170	100 Added 2.32%	4,404 $893,000
Q4 2019 Feb 04, 2020	SELL	$189.21 - $243.2 $4,541 - $5,836	-24 Reduced 0.55%	4,304 $1.04 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $48,924 - $58,622	-281 Reduced 6.1%	4,328 $837,000
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $768,320 - $900,644	4,609 New	4,609 $850,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellis Advisors, LLC with notifications on news.

Account